The role of implantable cardioverter-defibrillators in long-term dialysis patients

American Journal of Kidney Diseases

Volumn 58, Issue 3, 2011, Pages 338-339

  Lam, Ngan ^a   Leong Sit, Peter ^a   Garg, Amit X ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; DEVICE INFECTION; EDITORIAL; ELECTROLYTE DISTURBANCE; FLUID BALANCE; FOLLOW UP; HEALTH CARE COST; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HUMAN; INFECTION RISK; MEDICAL ETHICS; MORTALITY; MYOCARDIAL DISEASE; PRIMARY PREVENTION; SECONDARY PREVENTION; SEPSIS; SUDDEN DEATH; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE;

EID: 80051918118     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.07.003     Document Type: Editorial

References (14)

1. D.M. Charytan, A.R. Patrick, and J. Liu Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States Am J Kidney Dis 58 3 2011 409 417
2. US Renal Data System USRDS 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2006 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
3. A.J. Bleyer, G.B. Russell, and S.G. Satko Sudden and cardiac death rates in hemodialysis patients Kidney Int 55 4 1999 1553 1559 (Pubitemid 29157156)
4. K. Amann, and E. Ritz Cardiac disease in chronic uremia: pathophysiology Adv Ren Replace Ther 4 3 1997 212 224 (Pubitemid 27304996)
5. K. Amann, I. Rychlik, G. Miltenberger-Milteny, and E. Ritz Left ventricular hypertrophy in renal failure Kidney Int Suppl 68 1998 S78 S85
6. K. Amann, M. Buzello, and A. Simonaviciene Capillary/myocyte mismatch in the heart in renal failurea role for erythropoietin? Nephrol Dial Transplant 15 7 2000 964 969 (Pubitemid 30410366)
7. E. Ritz, K. Amann, J. Tornig, U. Schwarz, and G. Stein Some cardiac abnormalities in renal failure Adv Nephrol Necker Hosp 27 1997 85 103
8. S.G. Coca, H.M. Krumholz, A.X. Garg, and C.R. Parikh Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease JAMA 296 11 2006 1377 1384 (Pubitemid 44427424)
9. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237 (Pubitemid 40110811)
10. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 12 2002 877 883 (Pubitemid 34984635)
11. M.K. de Bie, D.B. van, and A. Gaasbeek The current status of interventions aiming at reducing sudden cardiac death in dialysis patients Eur Heart J 30 13 2009 1559 1564
12. J.L. Lin, P.S. Lim, M.L. Leu, and C.C. Huang Outcomes of severe hyperkalemia in cardiopulmonary resuscitation with concomitant hemodialysis Intensive Care Med 20 4 1994 287 290
13. J.J. Sims, A.W. Miller, and M.R. Ujhelyi Regional hyperkalemia increases ventricular defibrillation energy requirements: role of electrical heterogeneity in defibrillation J Cardiovasc Electrophysiol 11 6 2000 634 641 (Pubitemid 30397534)
14. Tompkins C, McLean R, Cheng A, Brinker JA, et al. End-stage renal disease predicts complications in pacemaker and ICD implants [published online ahead of print April 13, 2011]. J Cardiovasc Electrophysiol. doi:10.1111/j.1540-8167. 2011.02066.x.